NCT05437900 · ClinicalTrials.gov record · last posted 2026-01-12
INSIGHTFUL-FFR Clinical Trial
StatusRecruiting
PhasePhase 4
Started2022-09-22
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 12, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Recently, a new device for measuring physiological lesion severity, the pressure microcatheter, was introduced. The pressure microcatheter provides similar information to the conventional measurement technique but differs as it is easily advanced on a customary coronary wire and simplifies pullback maneuvers. The pressure microcatheter has been shown to provide comparable FFR results to pressure wires.
Insightful-FFR is an investigator-driven, multicenter, randomized, open-label and prospective trial of patients with stable coronary artery disease or stabilised non-ST elevation acute coronary syndrome (ACS) with epicardial stenosis considered for PCI aiming at comparing clinical outcomes between pressure microcatheter and pressure wire-guided strategies. The study hypothesis states that the use of a Pressure Microcatheter for clinical decision making would be non-inferior to pressure wire-based strategy
After determining the presence of a coronary artery disease/ stabilized acute coronary syndrome, patients will be randomized to use a pressure microcatheter (investigational device) or a pressure wire (comparator) to guide and optimize percutaneous coronary intervention (PCI). Patients will be followed up in hospital at 12 months and yearly until five years.
Amendment record
4 amendments on the ClinicalTrials.gov record
This ClinicalTrials.gov record has been amended 4 times since 2022-06-23; most recent amendment 2026-01-09. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history.
See every version on ClinicalTrials.gov ↗
2022-10-24
Status change Not Yet Recruiting→Recruitingv1
| NCT Number |
NCT05437900 |
| Lead Sponsor |
CoreAalst BV
Collaborators: Insight Lifetech Co., Ltd. |
| Conditions |
Coronary Artery Disease, Acute Coronary Syndrome |
| Enrollment |
2,500 participants |
| Start Date |
2022-09-22 |
| Primary Completion |
2026-06-30 (estimated) |
| Study Completion |
2030-06-30 (estimated) |
| Updated on ClinicalTrials.gov |
2026-01-12 |